The latest price target for Moelis (NYSE:MC) was reported by Goldman Sachs on February 6, 2025. The analyst firm set a price target for $87.00 expecting MC to rise to within 12 months (a possible 24.70% upside). 23 analyst firms have reported ratings in the last year.

The latest analyst rating for Moelis (NYSE:MC) was provided by Goldman Sachs, and Moelis maintained their neutral rating.

The last upgrade for Moelis & Co happened on December 20, 2024 when Keefe, Bruyette & Woods raised their price target to $86. Keefe, Bruyette & Woods previously had a market perform for Moelis & Co.

The last downgrade for Moelis & Co happened on January 11, 2023 when Goldman Sachs changed their price target from $40 to $37 for Moelis & Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moelis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moelis was filed on February 6, 2025 so you should expect the next rating to be made available sometime around February 6, 2026.

While ratings are subjective and will change, the latest Moelis (MC) rating was a maintained with a price target of $79.00 to $87.00. The current price Moelis (MC) is trading at is $69.77, which is out of the analyst’s predicted range.